Protecting Axonal Degeneration by Increasing Nicotinamide Adenine Dinucleotide Levels in Experimental Autoimmune Encephalomyelitis Models Protecting Axonal Degeneration by Increasing Nicotinamide Adenine Dinucleotide Levels in Experimental Autoimmune Encephalomyelitis Models2018-01-17T17:05:43-05:00
Ultraviolet B but not A Radiation Activates Suppressor B Cells in Draining Lymph Nodes Ultraviolet B but not A Radiation Activates Suppressor B Cells in Draining Lymph Nodes2018-01-17T17:05:43-05:00
Omega–6/Omega–3 Ratio and Brain-Related Functions Omega–6/Omega–3 Ratio and Brain-Related Functions2018-01-17T17:05:43-05:00
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS2018-01-17T17:05:43-05:00
Dietary Fat in Relation to Risk of Multiple Sclerosis among Two Large Cohorts of Women Dietary Fat in Relation to Risk of Multiple Sclerosis among Two Large Cohorts of Women2018-01-17T17:05:43-05:00
Eat dirt – the hygiene hypothesis and allergic diseases Eat dirt – the hygiene hypothesis and allergic diseases2018-01-17T17:05:43-05:00
High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis2018-01-17T17:05:43-05:00
Interferon beta in multiple sclerosis: how much BENEFIT? Interferon beta in multiple sclerosis: how much BENEFIT?2018-01-17T17:05:43-05:00
The initiation of the autoimmune response in multiple sclerosis The initiation of the autoimmune response in multiple sclerosis2018-01-17T17:05:43-05:00
Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis2018-01-17T17:05:43-05:00
